IONS
Price
$34.76
Change
+$0.65 (+1.91%)
Updated
Jun 3 closing price
Capitalization
5.53B
57 days until earnings call
ROIV
Price
$11.24
Change
+$0.07 (+0.63%)
Updated
Jun 3 closing price
Capitalization
7.64B
75 days until earnings call
Interact to see
Advertisement

IONS vs ROIV

Header iconIONS vs ROIV Comparison
Open Charts IONS vs ROIVBanner chart's image
Ionis Pharmaceuticals
Price$34.76
Change+$0.65 (+1.91%)
Volume$1.5M
Capitalization5.53B
Roivant Sciences
Price$11.24
Change+$0.07 (+0.63%)
Volume$5.1M
Capitalization7.64B
IONS vs ROIV Comparison Chart
Loading...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IONS vs. ROIV commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IONS is a Buy and ROIV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (IONS: $34.76 vs. ROIV: $11.24)
Brand notoriety: IONS and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IONS: 88% vs. ROIV: 79%
Market capitalization -- IONS: $5.53B vs. ROIV: $7.64B
IONS [@Biotechnology] is valued at $5.53B. ROIV’s [@Biotechnology] market capitalization is $7.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IONS’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • IONS’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than IONS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IONS’s TA Score shows that 5 TA indicator(s) are bullish while ROIV’s TA Score has 5 bullish TA indicator(s).

  • IONS’s TA Score: 5 bullish, 5 bearish.
  • ROIV’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than IONS.

Price Growth

IONS (@Biotechnology) experienced а +4.32% price change this week, while ROIV (@Biotechnology) price change was +4.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

IONS is expected to report earnings on Jul 31, 2025.

ROIV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.64B) has a higher market cap than IONS($5.53B). IONS YTD gains are higher at: -0.572 vs. ROIV (-4.945). ROIV has higher annual earnings (EBITDA): 4.1B vs. IONS (-357.21M). ROIV has more cash in the bank: 5.15B vs. IONS (2.15B). ROIV has less debt than IONS: ROIV (100M) vs IONS (1.41B). IONS has higher revenues than ROIV: IONS (717M) vs ROIV (123M).
IONSROIVIONS / ROIV
Capitalization5.53B7.64B72%
EBITDA-357.21M4.1B-9%
Gain YTD-0.572-4.94512%
P/E RatioN/A1.97-
Revenue717M123M583%
Total Cash2.15B5.15B42%
Total Debt1.41B100M1,410%
FUNDAMENTALS RATINGS
IONS: Fundamental Ratings
IONS
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IONSROIV
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 15 days ago
71%
Declines
ODDS (%)
Bearish Trend 13 days ago
70%
Bearish Trend 7 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HFRO5.140.08
+1.58%
Highland Opportunities and Income Fund
BCD33.130.08
+0.24%
abrdn Blmb AllCmdLDSK1Fr ETF
PSLV11.61N/A
N/A
Sprott Physical Silver Trust
DMA8.70-0.01
-0.11%
Destra Multi-Alternative Fund
FLSA32.90-0.12
-0.36%
Franklin FTSE Saudi Arabia ETF

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+0.67%
IMVT - ROIV
60%
Loosely correlated
+0.19%
ACLX - ROIV
53%
Loosely correlated
+5.18%
CRNX - ROIV
53%
Loosely correlated
+0.69%
CGON - ROIV
50%
Loosely correlated
+0.75%
KRYS - ROIV
50%
Loosely correlated
+4.43%
More